PHIO PHARMACEUTICALS CORP. (PHIO) Free cash flow 2016–2025
PHIO PHARMACEUTICALS CORP. (PHIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.0MFY2025 · since FY2016: -$7.8M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | -12.3% |
| FY2024 | -$7.1M | +33.9% |
| FY2023 | -$10.8M | +12.2% |
| FY2022 | -$12.3M | -2.9% |
| FY2021 | -$11.9M | -35.0% |
| FY2020 | -$8.8M | -1.2% |
| FY2019 | -$8.7M | -15.8% |
| FY2018 | -$7.5M | +22.6% |
| FY2017 | -$9.7M | -25.2% |
| FY2016 | -$7.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice